University Hospitals Bristol and Weston NHS Foundation Trust

• pipeline
• vaccelerate

• A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥ 18 Years of Age to <50 Years of Age : Study aims to assess the safety, tolerability and immunogenicity of mRNA-1769 in healthy adult participants

• Adults
• General population
• Monkeypox virus
• Mpox
• Pharmacological intervention
• Vaccination
• mRNA-1769

• Research Organization Registry (https://ror.org/03jzzxg14)

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to October 29, 2026